The Idylla SARS-CoV-2 test is targeted to help healthcare providers manage the COVID-19 pandemic through rapid and easy testing of individuals with flu-like symptoms. In addition, the Idylla SARS-CoV-2 test may be used in combination with the recently CE-marked IVD SeptiCyte&reg; RAPID Test on Idylla to facilitate the management of patients within the hospital intensive care unit .

Biocartis

Antwerp

Biocartis startup from Antwerp, Belgium is ranked 1080 out of 2449 worldwide and 13 from the 30 startups in Belgium. See more information and additional rankings on the StartupBlink Global Ecosystem Map